Hematology - Beverage fructose intake may lead to an abnormal cardiometabolic profile
Can't see this email? View it online
   
  Hematology  
  The latest hematology news from News Medical  
 

New clinical trial testing ApportALĀ® in post-covid syndromeNew clinical trial testing ApportAL® in post-covid syndrome

The virus that causes COVID-19 has long-term effects on some individuals, referred to as "chronic COVID syndrome" or "Long-COVID". The benefit of using ApportAL® has been objectively demonstrated on the improvement of muscle strength and physical performance.

Discover More Here
 
 Beverage fructose intake may lead to an abnormal cardiometabolic profileBeverage fructose intake may lead to an abnormal cardiometabolic profile
 
A new study describes that fructose intake from sugar-sweetened beverages can cause cardiometabolic disorders. In contrast, fruit fructose was found to be good for cardiometabolic health.
 
 
 Healthy gene found in centenarians can reverse the decline of heart performance in older peopleHealthy gene found in centenarians can reverse the decline of heart performance in older people
 
An anti-aging gene discovered in a population of centenarians has been shown to rewind the heart's biological age by 10 years.
 
 
 Mitochondrial dysfunction and endothelial impairment linked to many cardiovascular diseasesMitochondrial dysfunction and endothelial impairment linked to many cardiovascular diseases
 
Many cardiovascular diseases, such as atherosclerosis, or 'hardening of the arteries,' correlate to mitochondrial dysfunction and endothelial impairment in the tissues of the heart and blood vessels.
 
 Acquired mutations in 'Guardian of the Genome' accelerate the development of atherosclerosis
 
Acquired mutations in 'Guardian of the Genome' accelerate the development of atherosclerosisA team at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), working in collaboration with institutes in the USA, has demonstrated that acquired mutations in the gene encoding the protein p53 contribute to the development of atherosclerotic cardiovascular disease.
 
 
 MedUni Vienna researchers identify specific immune response to Epstein-Barr virus
 
MedUni Vienna researchers identify specific immune response to Epstein-Barr virusMedical science has not yet been able to explain why the Epstein-Barr virus triggers infectious mononucleosis (IM) in some people with initial infections and not in others.
 
 
 Cedars-Sinai's Stem Cell and Bone Marrow Transplant Program recognized with two major hallmarks of quality
 
Cedars-Sinai's Stem Cell and Bone Marrow Transplant Program recognized with two major hallmarks of qualityThe Stem Cell and Bone Marrow Transplant Program at Cedars-Sinai Cancer was recently recognized with two important hallmarks of quality: official accreditation for CAR T-cell therapy, and a third year in a row ranking among the top adult bone marrow transplant programs in the U.S.
 
 
 Researchers use single-cell RNA-sequencing to study the aging peripheral blood in mice
 
Researchers use single-cell RNA-sequencing to study the aging peripheral blood in miceA new research paper was published on the cover of Aging (listed as "Aging (Albany NY)" by Medline/PubMed and "Aging-US" by Web of Science) Volume 15, Issue 1, entitled, "Single-cell transcriptomics of peripheral blood in the aging mouse."
 
 
 More high-risk patients with pulmonary embolism may benefit from surgical intervention
 
More high-risk patients with pulmonary embolism may benefit from surgical interventionA new American Heart Association scientific statement suggests surgery be considered for more people with high-risk pulmonary embolism (PE).